Clinical trial
Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After…
NCT00465218 · Ottawa Heart Institute Research Corporation, Other · Completed
Key facts
| NCT number | NCT00465218 |
|---|---|
| Title | Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement |
| Official title | "Transcranial Doppler Assessment of Cerebral Embolization During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement: Comparison of High-dose Aspirin Versus Warfarin Plus Low-dose Aspirin" |
| Acronym | Tissue-Valve |
| Lead sponsor | Ottawa Heart Institute Research Corporation, Other |
| Collaborators | Edwards Lifesciences Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Aortic Valve Disease |
| Intervention type | Procedure |
| Interventions | Prophylaxis of Thrombosis after aortic valve replacement |
| Enrollment | 56 |
| Start date | Mar 1, 2007 |
| Primary completion | Dec 1, 2007 |
| Completion | Mar 1, 2011 |
| First posted | Apr 24, 2007 |
| Last update posted | Jun 21, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: